Archive for 'News'

The Next Generation De-Id Software

OTTAWA, ON. (NOVEMBER 19, 2014)  Privacy Analytics – the leading provider of software that safeguards and enables personal health data for secondary purposes – announced today the launch of PARAT 6.0 which for the first time gives health data organizations the ability to apply a proven de-identification methodology to complex data without the need for advanced technical skill and programming expertise. Read the official press release here.

The next generation of de-identification software ...

More →
0

Experts Point to Need for ‘Responsible’ De-id

TORONTO, ON. (OCTOBER 23, 2014) Protecting personal privacy while leveraging Big Data for important research and business analytics may be achieved with the currently available methods and protocols, according to a group of experts from the fields of privacy, de-identification, cryptography, and statistics. Privacy is a manufactured impediment to all of the social and commercial benefits of Big Data because there are already good ways to protect privacy.

This was the message delivered to professionals responsible for collecting, disclosing and using ...

More →
0

Intel’s The Data Opportunity

Intel’s The Data Opportunity: Rethinking Privacy to Spur Innovation

OTTAWA, ON. (October 10, 2014) On Wednesday, October 8th in San Francisco, Intel Corporation convened industry leaders in technology, healthcare, education and smart cities industries to encourage action on data privacy issues facing companies today. Malcolm Harkins, vice president and chief security and privacy officer for Intel, said that the potential to unlock revolutionary discoveries is at stake, and called on the industry to be more transparent and accountable when collecting and ...

More →
0

CenterWatch News Online | June 18, 2014

Privacy Analytics Launches Clinical Trials Data Sharing Solution

Privacy Analytics, a provider of data anonymization solutions for the healthcare industry, has launched a new solution to enable pharma companies to share clinical trials data while protecting the privacy of individual participants. The new offering accelerates the ability of pharma companies to meet increasing requests for individual-level participant data and clinical study reports by academic institutions, patients and other third parties. 

More →

0

PARAT Case Study | PARAT for Post Marketing and Public Health Surveillance

Privacy Analytics Enables Richer Insight into Anonymized Clinical Data

The Challenge:
Anonymize more than five years of clinical, prescription, laboratory, scheduling and billing data for more than 535,000 patients.

The Solution:
Apply PARAT to a complex longitudinal data set and leverage its insights for on-going and on-demand analytics.

The Benefit:
High-quality anonymized data for post-marketing and public health surveillance, prescription and health service analyses.

Privacy Analytics was approached by a leading healthcare analytics firm charged with providing de-identified data for a large EMR database consisting of nearly 535,595 patients in the province of Ontario. The complexity of the project ...

More →
0